Alpine Immune Sciences, Inc.
Alpine Immune Sciences, Inc.（ALPN）内幕交易
基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签；可在本季度与近12个月之间切换；下方为季度图与交易明细。
SEC EDGAR · FMP · ALPN · 截至 2026年6月9日
活动摘要
买入笔数
2
P-Purchase only
卖出笔数
33
近12个月
买卖比
0.06
Buy/Sell (by trades)
整体情绪
Alpine Immune Sciences, Inc.内部人在过去近12个月主要在卖出股份，卖出行为通常由预设的Rule 10b5-1计划驱动，不一定代表对公司的负面看法。
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale
截至 2026年6月9日
ALPN 季度内部人买卖趋势
ALPN 内幕交易卖出 · ALPN 内幕交易买入 · 季度活动
Mobile shows last 4Q · Desktop shows full 8Q
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 最近8季度
As of Jun 9, 2026
近期内幕交易记录
ALPN 高管卖出股份 · ALPN 董事内幕交易 · SEC Form 4申报
横向滑动查看全部列
| 日期 | 内部人 | 类型 | 股数 | 总金额 | 申报 |
|---|---|---|---|---|---|
| May 20, 2024 | Peetz Christopher Director | Other | 1,900 | $124K | Form 4 |
| May 20, 2024 | CONWAY ROBERT E Director | Other | 50,000 | $3.25M⚡ | Form 4 |
| May 18, 2024 | Topper James N Director | Other | 2,829,347 | $183.91M⚡ | Form 4 |
| May 18, 2024 | Thompson Peter A. Director | Other | 264,315 | $17.18M⚡ | Form 4 |
| May 18, 2024 | Cui Xiangmin Director | Other | 1,735,544 | $112.81M⚡ | Form 4 |
| May 20, 2024 | Rickey James Paul See Remarks | Other | 26,761 | $1.74M⚡ | Form 4 |
| May 20, 2024 | Rickey James Paul See Remarks | Other | 31,200 | $2.03M⚡ | Form 4 |
| May 20, 2024 | PENG STANFORD L See Remarks | Other | 296,163 | $19.25M⚡ | Form 4 |
| May 20, 2024 | PENG STANFORD L See Remarks | Other | 48,000 | $3.12M⚡ | Form 4 |
| May 20, 2024 | GOLD MITCHELL Executive Chairman and CEO · Director | Other | 13,245 | $861K | Form 4 |
| May 18, 2024 | GOLD MITCHELL Executive Chairman and CEO · Director | Other | 2,627,157 | $170.77M⚡ | Form 4 |
| May 20, 2024 | GOLD MITCHELL Executive Chairman and CEO · Director | Other | 96,000 | $6.24M⚡ | Form 4 |
| May 20, 2024 | FUHS ULRICH MARTIN CAO | Other | 22,820 | $1.48M⚡ | Form 4 |
| May 20, 2024 | FUHS ULRICH MARTIN CAO | Other | 7,300 | $475K | Form 4 |
| May 20, 2024 | DURAND REMY Chief Business Officer | Other | 102,192 | $6.64M⚡ | Form 4 |
| May 20, 2024 | DURAND REMY Chief Business Officer | Other | 31,200 | $2.03M⚡ | Form 4 |
| May 18, 2024 | ORBIMED ADVISORS LLC Director | Other | 264,315 | $17.18M⚡ | Form 4 |
| May 8, 2024 | PENG STANFORD L See Remarks | Option | 13,377 | $85K | Form 4 |
| May 8, 2024 | PENG STANFORD L See Remarks | Option | 26,912 | $87K | Form 4 |
| May 8, 2024 | PENG STANFORD L See Remarks | Option | 22,593 | $256K | Form 4 |
GOLD MITCHELL
Executive Chairman and CEO · Director
日期
May 20
股数
13,245
均价
$65.00
总金额
$861K
GOLD MITCHELL
Executive Chairman and CEO · Director
日期
May 18
股数
2,627,157
均价
$65.00
总金额
$170.77M ⚡
GOLD MITCHELL
Executive Chairman and CEO · Director
日期
May 20
股数
96,000
均价
$65.00
总金额
$6.24M ⚡
▸ 数据来源：SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —
关于 ALPN 内幕交易
ALPN 内幕交易
Alpine Immune Sciences, Inc.（ALPN）内幕交易数据来源于公司内部人（包括ALPN）提交的SEC Form 4申报文件。过去12个月内，0位内部人向SEC提交了交易申报。ALPN内部人近期主要在卖出，这可能反映预设的10b5-1计划执行，而非方向性判断。
如需查看Alpine Immune Sciences, Inc.机构持仓比例和内部人持股百分比，请访问持仓（Ownership）标签页 → Ownership tab →
常见问题
ALPN 内幕交易 · 5个问题Alpine Immune Sciences, Inc.（ALPN）的内部人包括高管和董事，如ALPN等。过去12个月内，0位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。
▸ 数据来源：FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 9, 2026